 | • レポートコード：GIR201109992 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、チロシンキナーゼJAK阻害剤の世界市場を調査対象にし、チロシンキナーゼJAK阻害剤の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（トファシチニブ、ルキソリチニブ、バリシチニブ）、用途別分析（関節リウマチ（RA）、真性赤血球増加症（PCV）、骨髄線維症（MF）、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Pfizer、AbbVie、Eli Lilly、Incyte、Galapagos、Novartis、Teva、Sanofi、Gilead、Vertex、Astellas Pharma、Celgene、CTI BioPharma ・メーカー別販売量、売上、市場シェア ・チロシンキナーゼJAK阻害剤の地域別市場分析 ・チロシンキナーゼJAK阻害剤の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・チロシンキナーゼJAK阻害剤のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・チロシンキナーゼJAK阻害剤のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・チロシンキナーゼJAK阻害剤の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・チロシンキナーゼJAK阻害剤の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・チロシンキナーゼJAK阻害剤の種類別市場規模2015-2020：トファシチニブ、ルキソリチニブ、バリシチニブ ・チロシンキナーゼJAK阻害剤の用途別市場規模2015-2020：関節リウマチ（RA）、真性赤血球増加症（PCV）、骨髄線維症（MF）、その他 ・チロシンキナーゼJAK阻害剤の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The Tyrosine Kinase JAK Inhibitors market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Tyrosine Kinase JAK Inhibitors market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 58.9%% in the forecast period of 2020 to 2025 and will expected to reach USD 71130 million by 2025, from USD 11170 million in 2019.
Market segmentation
Tyrosine Kinase JAK Inhibitors market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Tyrosine Kinase JAK Inhibitors market has been segmented into
Tofacitinib
Ruxolitinib
Baricitinib
By Application, Tyrosine Kinase JAK Inhibitors has been segmented into:
Rheumatoid Arthritis (RA)
Polycythemia Vera (PCV)
Myelofibrosis (MF)
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Tyrosine Kinase JAK Inhibitors market presented in the report. This section sheds light on the sales growth of different regional and country-level Tyrosine Kinase JAK Inhibitors markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Tyrosine Kinase JAK Inhibitors market.
The report offers in-depth assessment of the growth and other aspects of the Tyrosine Kinase JAK Inhibitors market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Tyrosine Kinase JAK Inhibitors Market Share Analysis
Tyrosine Kinase JAK Inhibitors competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Tyrosine Kinase JAK Inhibitors sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Tyrosine Kinase JAK Inhibitors sales, revenue and market share for each player covered in this report.
The major players covered in Tyrosine Kinase JAK Inhibitors are:
Pfizer
AbbVie
Eli Lilly
Incyte
Galapagos
Novartis
Teva
Sanofi
Gilead
Vertex
Astellas Pharma
Celgene
CTI BioPharma
Among other players domestic and global, Tyrosine Kinase JAK Inhibitors market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Tyrosine Kinase JAK Inhibitors product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Tyrosine Kinase JAK Inhibitors, with price, sales, revenue and global market share of Tyrosine Kinase JAK Inhibitors in 2018 and 2019.
Chapter 3, the Tyrosine Kinase JAK Inhibitors competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Tyrosine Kinase JAK Inhibitors breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Tyrosine Kinase JAK Inhibitors market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Tyrosine Kinase JAK Inhibitors sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Tyrosine Kinase JAK Inhibitors Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Tyrosine Kinase JAK Inhibitors Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Tofacitinib
1.2.3 Ruxolitinib
1.2.4 Baricitinib
1.3 Market Analysis by Application
1.3.1 Overview: Global Tyrosine Kinase JAK Inhibitors Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Rheumatoid Arthritis (RA)
1.3.3 Polycythemia Vera (PCV)
1.3.4 Myelofibrosis (MF)
1.3.5 Others
1.4 Overview of Global Tyrosine Kinase JAK Inhibitors Market
1.4.1 Global Tyrosine Kinase JAK Inhibitors Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Tyrosine Kinase JAK Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 AbbVie
2.2.1 AbbVie Details
2.2.2 AbbVie Major Business
2.2.3 AbbVie SWOT Analysis
2.2.4 AbbVie Product and Services
2.2.5 AbbVie Tyrosine Kinase JAK Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Eli Lilly
2.3.1 Eli Lilly Details
2.3.2 Eli Lilly Major Business
2.3.3 Eli Lilly SWOT Analysis
2.3.4 Eli Lilly Product and Services
2.3.5 Eli Lilly Tyrosine Kinase JAK Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Incyte
2.4.1 Incyte Details
2.4.2 Incyte Major Business
2.4.3 Incyte SWOT Analysis
2.4.4 Incyte Product and Services
2.4.5 Incyte Tyrosine Kinase JAK Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Galapagos
2.5.1 Galapagos Details
2.5.2 Galapagos Major Business
2.5.3 Galapagos SWOT Analysis
2.5.4 Galapagos Product and Services
2.5.5 Galapagos Tyrosine Kinase JAK Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business
2.6.3 Novartis Product and Services
2.6.4 Novartis Tyrosine Kinase JAK Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Teva
2.7.1 Teva Details
2.7.2 Teva Major Business
2.7.3 Teva Product and Services
2.7.4 Teva Tyrosine Kinase JAK Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Sanofi
2.8.1 Sanofi Details
2.8.2 Sanofi Major Business
2.8.3 Sanofi Product and Services
2.8.4 Sanofi Tyrosine Kinase JAK Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Gilead
2.9.1 Gilead Details
2.9.2 Gilead Major Business
2.9.3 Gilead Product and Services
2.9.4 Gilead Tyrosine Kinase JAK Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Vertex
2.10.1 Vertex Details
2.10.2 Vertex Major Business
2.10.3 Vertex Product and Services
2.10.4 Vertex Tyrosine Kinase JAK Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Astellas Pharma
2.11.1 Astellas Pharma Details
2.11.2 Astellas Pharma Major Business
2.11.3 Astellas Pharma Product and Services
2.11.4 Astellas Pharma Tyrosine Kinase JAK Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Celgene
2.12.1 Celgene Details
2.12.2 Celgene Major Business
2.12.3 Celgene Product and Services
2.12.4 Celgene Tyrosine Kinase JAK Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 CTI BioPharma
2.13.1 CTI BioPharma Details
2.13.2 CTI BioPharma Major Business
2.13.3 CTI BioPharma Product and Services
2.13.4 CTI BioPharma Tyrosine Kinase JAK Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Tyrosine Kinase JAK Inhibitors Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Tyrosine Kinase JAK Inhibitors Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Tyrosine Kinase JAK Inhibitors Manufacturer Market Share in 2019
3.3.2 Top 6 Tyrosine Kinase JAK Inhibitors Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Tyrosine Kinase JAK Inhibitors Sales, Revenue and Market Share by Regions
4.1.1 Global Tyrosine Kinase JAK Inhibitors Sales and Market Share by Regions (2015-2020)
4.1.2 Global Tyrosine Kinase JAK Inhibitors Revenue and Market Share by Regions (2015-2020)
4.2 North America Tyrosine Kinase JAK Inhibitors Sales and Growth Rate (2015-2020)
4.3 Europe Tyrosine Kinase JAK Inhibitors Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Tyrosine Kinase JAK Inhibitors Sales and Growth Rate (2015-2020)
4.5 South America Tyrosine Kinase JAK Inhibitors Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Tyrosine Kinase JAK Inhibitors Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Tyrosine Kinase JAK Inhibitors Sales, Revenue and Market Share by Country
5.1.1 North America Tyrosine Kinase JAK Inhibitors Sales and Market Share by Country (2015-2020)
5.1.2 North America Tyrosine Kinase JAK Inhibitors Revenue and Market Share by Country (2015-2020)
5.2 United States Tyrosine Kinase JAK Inhibitors Sales and Growth Rate (2015-2020)
5.3 Canada Tyrosine Kinase JAK Inhibitors Sales and Growth Rate (2015-2020)
5.4 Mexico Tyrosine Kinase JAK Inhibitors Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Tyrosine Kinase JAK Inhibitors Sales, Revenue and Market Share by Country
6.1.1 Europe Tyrosine Kinase JAK Inhibitors Sales and Market Share by Country (2015-2020)
6.1.2 Europe Tyrosine Kinase JAK Inhibitors Revenue and Market Share by Country (2015-2020)
6.2 Germany Tyrosine Kinase JAK Inhibitors Sales and Growth Rate (2015-2020)
6.3 UK Tyrosine Kinase JAK Inhibitors Sales and Growth Rate (2015-2020)
6.4 France Tyrosine Kinase JAK Inhibitors Sales and Growth Rate (2015-2020)
6.5 Russia Tyrosine Kinase JAK Inhibitors Sales and Growth Rate (2015-2020)
6.6 Italy Tyrosine Kinase JAK Inhibitors Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Tyrosine Kinase JAK Inhibitors Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Tyrosine Kinase JAK Inhibitors Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Tyrosine Kinase JAK Inhibitors Revenue and Market Share by Regions (2015-2020)
7.2 China Tyrosine Kinase JAK Inhibitors Sales and Growth Rate (2015-2020)
7.3 Japan Tyrosine Kinase JAK Inhibitors Sales and Growth Rate (2015-2020)
7.4 Korea Tyrosine Kinase JAK Inhibitors Sales and Growth Rate (2015-2020)
7.5 India Tyrosine Kinase JAK Inhibitors Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Tyrosine Kinase JAK Inhibitors Sales and Growth Rate (2015-2020)
7.7 Australia Tyrosine Kinase JAK Inhibitors Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Tyrosine Kinase JAK Inhibitors Sales, Revenue and Market Share by Country
8.1.1 South America Tyrosine Kinase JAK Inhibitors Sales and Market Share by Country (2015-2020)
8.1.2 South America Tyrosine Kinase JAK Inhibitors Revenue and Market Share by Country (2015-2020)
8.2 Brazil Tyrosine Kinase JAK Inhibitors Sales and Growth Rate (2015-2020)
8.3 Argentina Tyrosine Kinase JAK Inhibitors Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Tyrosine Kinase JAK Inhibitors Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Tyrosine Kinase JAK Inhibitors Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Tyrosine Kinase JAK Inhibitors Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Tyrosine Kinase JAK Inhibitors Sales and Growth Rate (2015-2020)
9.3 Turkey Tyrosine Kinase JAK Inhibitors Sales and Growth Rate (2015-2020)
9.4 Egypt Tyrosine Kinase JAK Inhibitors Sales and Growth Rate (2015-2020)
9.5 South Africa Tyrosine Kinase JAK Inhibitors Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Tyrosine Kinase JAK Inhibitors Sales and Market Share by Type (2015-2020)
10.2 Global Tyrosine Kinase JAK Inhibitors Revenue and Market Share by Type (2015-2020)
10.3 Global Tyrosine Kinase JAK Inhibitors Price by Type (2015-2020)
11 Global Tyrosine Kinase JAK Inhibitors Market Segment by Application
11.1 Global Tyrosine Kinase JAK Inhibitors Sales Market Share by Application (2015-2020)
11.2 Global Tyrosine Kinase JAK Inhibitors Revenue Market Share by Application (2015-2020)
11.3 Global Tyrosine Kinase JAK Inhibitors Price by Application (2015-2020)
12 Market Forecast
12.1 Global Tyrosine Kinase JAK Inhibitors Sales, Revenue and Growth Rate (2021-2025)
12.2 Tyrosine Kinase JAK Inhibitors Market Forecast by Regions (2021-2025)
12.2.1 North America Tyrosine Kinase JAK Inhibitors Market Forecast (2021-2025)
12.2.2 Europe Tyrosine Kinase JAK Inhibitors Market Forecast (2021-2025)
12.2.3 Asia-Pacific Tyrosine Kinase JAK Inhibitors Market Forecast (2021-2025)
12.2.4 South America Tyrosine Kinase JAK Inhibitors Market Forecast (2021-2025)
12.2.5 Middle East & Africa Tyrosine Kinase JAK Inhibitors Market Forecast (2021-2025)
12.3 Tyrosine Kinase JAK Inhibitors Market Forecast by Type (2021-2025)
12.3.1 Global Tyrosine Kinase JAK Inhibitors Sales Forecast by Type (2021-2025)
12.3.2 Global Tyrosine Kinase JAK Inhibitors Market Share Forecast by Type (2021-2025)
12.4 Tyrosine Kinase JAK Inhibitors Market Forecast by Application (2021-2025)
12.4.1 Global Tyrosine Kinase JAK Inhibitors Sales Forecast by Application (2021-2025)
12.4.2 Global Tyrosine Kinase JAK Inhibitors Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Tyrosine Kinase JAK Inhibitors Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Tyrosine Kinase JAK Inhibitors by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Tyrosine Kinase JAK Inhibitors Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Tyrosine Kinase JAK Inhibitors Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Pfizer Basic Information, Manufacturing Base and Competitors
Table 9. Pfizer Tyrosine Kinase JAK Inhibitors Major Business
Table 10. Pfizer Tyrosine Kinase JAK Inhibitors Total Revenue (USD Million) (2018-2019)
Table 11. Pfizer SWOT Analysis
Table 12. Pfizer Tyrosine Kinase JAK Inhibitors Product and Services
Table 13. Pfizer Tyrosine Kinase JAK Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. AbbVie Basic Information, Manufacturing Base and Competitors
Table 15. AbbVie Tyrosine Kinase JAK Inhibitors Major Business
Table 16. AbbVie Tyrosine Kinase JAK Inhibitors Total Revenue (USD Million) (2018-2019)
Table 17. AbbVie SWOT Analysis
Table 18. AbbVie Tyrosine Kinase JAK Inhibitors Product and Services
Table 19. AbbVie Tyrosine Kinase JAK Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 21. Eli Lilly Tyrosine Kinase JAK Inhibitors Major Business
Table 22. Eli Lilly Tyrosine Kinase JAK Inhibitors Total Revenue (USD Million) (2018-2019)
Table 23. Eli Lilly SWOT Analysis
Table 24. Eli Lilly Tyrosine Kinase JAK Inhibitors Product and Services
Table 25. Eli Lilly Tyrosine Kinase JAK Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Incyte Basic Information, Manufacturing Base and Competitors
Table 27. Incyte Tyrosine Kinase JAK Inhibitors Major Business
Table 28. Incyte Tyrosine Kinase JAK Inhibitors Total Revenue (USD Million) (2018-2019)
Table 29. Incyte SWOT Analysis
Table 30. Incyte Tyrosine Kinase JAK Inhibitors Product and Services
Table 31. Incyte Tyrosine Kinase JAK Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Galapagos Basic Information, Manufacturing Base and Competitors
Table 33. Galapagos Tyrosine Kinase JAK Inhibitors Major Business
Table 34. Galapagos Tyrosine Kinase JAK Inhibitors Total Revenue (USD Million) (2018-2019)
Table 35. Galapagos SWOT Analysis
Table 36. Galapagos Tyrosine Kinase JAK Inhibitors Product and Services
Table 37. Galapagos Tyrosine Kinase JAK Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Novartis Basic Information, Manufacturing Base and Competitors
Table 39. Novartis Tyrosine Kinase JAK Inhibitors Major Business
Table 40. Novartis Tyrosine Kinase JAK Inhibitors Total Revenue (USD Million) (2018-2019)
Table 41. Novartis SWOT Analysis
Table 42. Novartis Tyrosine Kinase JAK Inhibitors Product and Services
Table 43. Novartis Tyrosine Kinase JAK Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Teva Basic Information, Manufacturing Base and Competitors
Table 45. Teva Tyrosine Kinase JAK Inhibitors Major Business
Table 46. Teva Tyrosine Kinase JAK Inhibitors Total Revenue (USD Million) (2018-2019)
Table 47. Teva SWOT Analysis
Table 48. Teva Tyrosine Kinase JAK Inhibitors Product and Services
Table 49. Teva Tyrosine Kinase JAK Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Sanofi Basic Information, Manufacturing Base and Competitors
Table 51. Sanofi Tyrosine Kinase JAK Inhibitors Major Business
Table 52. Sanofi Tyrosine Kinase JAK Inhibitors Total Revenue (USD Million) (2018-2019)
Table 53. Sanofi SWOT Analysis
Table 54. Sanofi Tyrosine Kinase JAK Inhibitors Product and Services
Table 55. Sanofi Tyrosine Kinase JAK Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Gilead Basic Information, Manufacturing Base and Competitors
Table 57. Gilead Tyrosine Kinase JAK Inhibitors Major Business
Table 58. Gilead Tyrosine Kinase JAK Inhibitors Total Revenue (USD Million) (2018-2019)
Table 59. Gilead SWOT Analysis
Table 60. Gilead Tyrosine Kinase JAK Inhibitors Product and Services
Table 61. Gilead Tyrosine Kinase JAK Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. Vertex Basic Information, Manufacturing Base and Competitors
Table 63. Vertex Tyrosine Kinase JAK Inhibitors Major Business
Table 64. Vertex Tyrosine Kinase JAK Inhibitors Total Revenue (USD Million) (2018-2019)
Table 65. Vertex SWOT Analysis
Table 66. Vertex Tyrosine Kinase JAK Inhibitors Product and Services
Table 67. Vertex Tyrosine Kinase JAK Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 68. Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table 69. Astellas Pharma Tyrosine Kinase JAK Inhibitors Major Business
Table 70. Astellas Pharma Tyrosine Kinase JAK Inhibitors Total Revenue (USD Million) (2018-2019)
Table 71. Astellas Pharma SWOT Analysis
Table 72. Astellas Pharma Tyrosine Kinase JAK Inhibitors Product and Services
Table 73. Astellas Pharma Tyrosine Kinase JAK Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 74. Celgene Basic Information, Manufacturing Base and Competitors
Table 75. Celgene Tyrosine Kinase JAK Inhibitors Major Business
Table 76. Celgene Tyrosine Kinase JAK Inhibitors Total Revenue (USD Million) (2018-2019)
Table 77. Celgene SWOT Analysis
Table 78. Celgene Tyrosine Kinase JAK Inhibitors Product and Services
Table 79. Celgene Tyrosine Kinase JAK Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 80. CTI BioPharma Basic Information, Manufacturing Base and Competitors
Table 81. CTI BioPharma Tyrosine Kinase JAK Inhibitors Major Business
Table 82. CTI BioPharma Tyrosine Kinase JAK Inhibitors Total Revenue (USD Million) (2018-2019)
Table 83. CTI BioPharma SWOT Analysis
Table 84. CTI BioPharma Tyrosine Kinase JAK Inhibitors Product and Services
Table 85. CTI BioPharma Tyrosine Kinase JAK Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 86. Global Tyrosine Kinase JAK Inhibitors Sales by Manufacturer (2018-2019) (K Units)
Table 87. Global Tyrosine Kinase JAK Inhibitors Revenue by Manufacturer (2018-2019) (USD Million)
Table 88. Global Tyrosine Kinase JAK Inhibitors Sales by Regions (2015-2020) (K Units)
Table 89. Global Tyrosine Kinase JAK Inhibitors Sales Market Share by Regions (2015-2020)
Table 90. Global Tyrosine Kinase JAK Inhibitors Revenue by Regions (2015-2020) (USD Million)
Table 91. North America Tyrosine Kinase JAK Inhibitors Sales by Countries (2015-2020) (K Units)
Table 92. North America Tyrosine Kinase JAK Inhibitors Sales Market Share by Countries (2015-2020)
Table 93. North America Tyrosine Kinase JAK Inhibitors Revenue by Countries (2015-2020) (USD Million)
Table 94. North America Tyrosine Kinase JAK Inhibitors Revenue Market Share by Countries (2015-2020)
Table 95. Europe Tyrosine Kinase JAK Inhibitors Sales by Countries (2015-2020) (K Units)
Table 96. Europe Tyrosine Kinase JAK Inhibitors Sales Market Share by Countries (2015-2020)
Table 97. Europe Tyrosine Kinase JAK Inhibitors Revenue by Countries (2015-2020) (USD Million)
Table 98. Asia-Pacific Tyrosine Kinase JAK Inhibitors Sales by Regions (2015-2020) (K Units)
Table 99. Asia-Pacific Tyrosine Kinase JAK Inhibitors Sales Market Share by Regions (2015-2020)
Table 100. Asia-Pacific Tyrosine Kinase JAK Inhibitors Revenue by Regions (2015-2020) (USD Million)
Table 101. South America Tyrosine Kinase JAK Inhibitors Sales by Countries (2015-2020) (K Units)
Table 102. South America Tyrosine Kinase JAK Inhibitors Sales Market Share by Countries (2015-2020)
Table 103. South America Tyrosine Kinase JAK Inhibitors Revenue by Countries (2015-2020) (USD Million)
Table 104. South America Tyrosine Kinase JAK Inhibitors Revenue Market Share by Countries (2015-2020)
Table 105. Middle East & Africa Tyrosine Kinase JAK Inhibitors Sales by Countries (2015-2020) (K Units)
Table 106. Middle East & Africa Tyrosine Kinase JAK Inhibitors Sales Market Share by Countries (2015-2020)
Table 107. Middle East & Africa Tyrosine Kinase JAK Inhibitors Revenue by Countries (2015-2020) (USD Million)
Table 108. Middle East & Africa Tyrosine Kinase JAK Inhibitors Revenue Market Share by Countries (2015-2020)
Table 109. Global Tyrosine Kinase JAK Inhibitors Sales by Type (2015-2020) (K Units)
Table 110. Global Tyrosine Kinase JAK Inhibitors Sales Share by Type (2015-2020)
Table 111. Global Tyrosine Kinase JAK Inhibitors Revenue by Type (2015-2020) (USD Million)
Table 112. Global Tyrosine Kinase JAK Inhibitors Revenue Share by Type (2015-2020)
Table 113. Global Tyrosine Kinase JAK Inhibitors Sales by Application (2015-2020) (K Units)
Table 114. Global Tyrosine Kinase JAK Inhibitors Sales Share by Application (2015-2020)
Table 115. Global Tyrosine Kinase JAK Inhibitors Sales Forecast by Regions (2021-2025) (K Units)
Table 116. Global Tyrosine Kinase JAK Inhibitors Market Share Forecast by Regions (2021-2025)
Table 117. Global Tyrosine Kinase JAK Inhibitors Sales Forecast by Type (2021-2025) (K Units)
Table 118. Global Tyrosine Kinase JAK Inhibitors Market Share Forecast by Type (2021-2025)
Table 119. Global Tyrosine Kinase JAK Inhibitors Sales Forecast by Application (2021-2025)
Table 120. Global Tyrosine Kinase JAK Inhibitors Market Share Forecast by Application (2021-2025)
Table 121. Direct Channel Pros & Cons
Table 122. Indirect Channel Pros & Cons
Table 123. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Tyrosine Kinase JAK Inhibitors Picture
Figure 2. Global Sales Market Share of Tyrosine Kinase JAK Inhibitors by Type in 2019
Figure 3. Tofacitinib Picture
Figure 4. Ruxolitinib Picture
Figure 5. Baricitinib Picture
Figure 6. Tyrosine Kinase JAK Inhibitors Sales Market Share by Application in 2019
Figure 7. Rheumatoid Arthritis (RA) Picture
Figure 8. Polycythemia Vera (PCV) Picture
Figure 9. Myelofibrosis (MF) Picture
Figure 10. Others Picture
Figure 11. Global Tyrosine Kinase JAK Inhibitors Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Tyrosine Kinase JAK Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Tyrosine Kinase JAK Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Tyrosine Kinase JAK Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Tyrosine Kinase JAK Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Tyrosine Kinase JAK Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Tyrosine Kinase JAK Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Tyrosine Kinase JAK Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Tyrosine Kinase JAK Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Tyrosine Kinase JAK Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Tyrosine Kinase JAK Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Tyrosine Kinase JAK Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Tyrosine Kinase JAK Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Tyrosine Kinase JAK Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Tyrosine Kinase JAK Inhibitors Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Tyrosine Kinase JAK Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Tyrosine Kinase JAK Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Tyrosine Kinase JAK Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Tyrosine Kinase JAK Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Tyrosine Kinase JAK Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Tyrosine Kinase JAK Inhibitors Sales Market Share by Manufacturer in 2019
Figure 32. Global Tyrosine Kinase JAK Inhibitors Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Tyrosine Kinase JAK Inhibitors Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Tyrosine Kinase JAK Inhibitors Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Tyrosine Kinase JAK Inhibitors Sales and Growth Rate (2015-2020) (K Units)
Figure 37. Global Tyrosine Kinase JAK Inhibitors Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Tyrosine Kinase JAK Inhibitors Revenue Market Share by Regions (2015-2020)
Figure 39. Global Tyrosine Kinase JAK Inhibitors Revenue Market Share by Regions in 2018
Figure 40. North America Tyrosine Kinase JAK Inhibitors Sales and Growth Rate (2015-2020)
Figure 41. Europe Tyrosine Kinase JAK Inhibitors Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Tyrosine Kinase JAK Inhibitors Sales and Growth Rate (2015-2020)
Figure 43. South America Tyrosine Kinase JAK Inhibitors Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Tyrosine Kinase JAK Inhibitors Sales and Growth Rate (2015-2020)
Figure 45. North America Tyrosine Kinase JAK Inhibitors Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Tyrosine Kinase JAK Inhibitors Sales Market Share by Countries (2015-2020)
Figure 47. North America Tyrosine Kinase JAK Inhibitors Sales Market Share by Countries in 2018
Figure 48. North America Tyrosine Kinase JAK Inhibitors Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Tyrosine Kinase JAK Inhibitors Revenue Market Share by Countries in 2018
Figure 50. United States Tyrosine Kinase JAK Inhibitors Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Canada Tyrosine Kinase JAK Inhibitors Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Mexico Tyrosine Kinase JAK Inhibitors Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Europe Tyrosine Kinase JAK Inhibitors Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Tyrosine Kinase JAK Inhibitors Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Tyrosine Kinase JAK Inhibitors Revenue Market Share by Countries in 2019
Figure 56. Germany Tyrosine Kinase JAK Inhibitors Sales and Growth Rate (2015-2020) (K Units)
Figure 57. UK Tyrosine Kinase JAK Inhibitors Sales and Growth Rate (2015-2020) (K Units)
Figure 58. France Tyrosine Kinase JAK Inhibitors Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Russia Tyrosine Kinase JAK Inhibitors Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Italy Tyrosine Kinase JAK Inhibitors Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Asia-Pacific Tyrosine Kinase JAK Inhibitors Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Tyrosine Kinase JAK Inhibitors Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Tyrosine Kinase JAK Inhibitors Revenue Market Share by Regions 2019
Figure 64. China Tyrosine Kinase JAK Inhibitors Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Japan Tyrosine Kinase JAK Inhibitors Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Korea Tyrosine Kinase JAK Inhibitors Sales and Growth Rate (2015-2020) (K Units)
Figure 67. India Tyrosine Kinase JAK Inhibitors Sales and Growth Rate (2015-2020) (K Units)
Figure 68. Southeast Asia Tyrosine Kinase JAK Inhibitors Sales and Growth Rate (2015-2020) (K Units)
Figure 69. South America Tyrosine Kinase JAK Inhibitors Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Tyrosine Kinase JAK Inhibitors Sales Market Share by Countries in 2019
Figure 71. South America Tyrosine Kinase JAK Inhibitors Revenue Market Share by Countries in 2019
Figure 72. Brazil Tyrosine Kinase JAK Inhibitors Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Argentina Tyrosine Kinase JAK Inhibitors Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Middle East and Africa Tyrosine Kinase JAK Inhibitors Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Tyrosine Kinase JAK Inhibitors Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Tyrosine Kinase JAK Inhibitors Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Tyrosine Kinase JAK Inhibitors Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Tyrosine Kinase JAK Inhibitors Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Egypt Tyrosine Kinase JAK Inhibitors Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Turkey Tyrosine Kinase JAK Inhibitors Sales and Growth Rate (2015-2020) (K Units)
Figure 81. South Africa Tyrosine Kinase JAK Inhibitors Sales and Growth Rate (2015-2020) (K Units)
Figure 82. Global Tyrosine Kinase JAK Inhibitors Sales and Growth Rate (2021-2025) (K Units)
Figure 83. Global Tyrosine Kinase JAK Inhibitors Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Tyrosine Kinase JAK Inhibitors Market Forecast (2021-2025) (K Units)
Figure 85. Europe Sales Tyrosine Kinase JAK Inhibitors Market Forecast (2021-2025) (K Units)
Figure 86. Asia-Pacific Sales Tyrosine Kinase JAK Inhibitors Market Forecast (2021-2025) (K Units)
Figure 87. South America Sales Tyrosine Kinase JAK Inhibitors Market Forecast (2021-2025) (K Units)
Figure 88. Middle East & Africa Sales Tyrosine Kinase JAK Inhibitors Market Forecast (2021-2025) (K Units)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel
チロシンキナーゼ阻害剤の世界市場 2020年 Market Overview The global Tyrosine Kinase Inhibitors market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tyrosine Kinase In…- チロシンプロテインキナーゼCSKの世界市場 2020年 Market Overview The global Tyrosine Protein Kinase CSK market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tyrosine Protein …
- チロシンプロテインキナーゼLynの世界市場 2020年 Market Overview The global Tyrosine Protein Kinase Lyn market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tyrosine Protein …
- チロシンプロテインキナーゼFynの世界市場 2020年 Market Overview The global Tyrosine Protein Kinase Fyn market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tyrosine Protein …
- チロシンプロテインキナーゼ受容体TYRO3の世界市場 2020年 Market Overview The global Tyrosine Protein Kinase Receptor TYRO3 market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tyrosi…